Inhibition of Hemangioma Development in a Syngeneic Mouse Model Correlates With BCL-2 Suppression and the Inhibition of Akt Kinase Activity

Angiogenesis - Netherlands
doi 10.1007/s10456-011-9248-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Inhibition of EGFR-AKT Axis Results in the Suppression of Ovarian Tumors in Vitro and in Preclinical Mouse Model

PLoS ONE
Multidisciplinary
2012English

Mechanism of BCL-2 and BCL-Xl Inhibition of NLRP1 Inflammasome: Loop Domain-Dependent Suppression of ATP Binding and Oligomerization

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

Inhibition of Sphingosine Kinase-2 in a Murine Model of Lupus Nephritis

PLoS ONE
Multidisciplinary
2013English

BCL-2 Inhibition: Stemming the Tide of Myeloid Malignancies

Cell Stem Cell
Molecular MedicineGeneticsCell Biology
2013English

Jacarelhyperol a Induced Apoptosis in Leukaemia Cancer Cell Through Inhibition the Activity of BCL-2 Proteins

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Overexpression of BCL-xL Promotes Chemotherapy Resistance of Mammary Tumors in a Syngeneic Mouse Model

American Journal of Pathology
Forensic MedicinePathology
1999English

Effects of Dipeptidyl Peptidase-4 Inhibition With MK-0431 on Syngeneic Mouse Islet Transplantation

International Journal of Endocrinology
EndocrineEndocrinologyMetabolismAutonomic SystemsDiabetes
2014English

Development of a Syngeneic Mouse Model of Epithelial Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2010English

Inhibition of Fas-Induced Apoptosis by BCL-2

Oncogene
Cancer ResearchGeneticsMolecular Biology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy